StockComparison Logo
vs

CGTX vs MXCT

Comparison between Cognition Therapeutics Inc (CGTX, Company) and MaxCyte Inc (MXCT, Company).

Both CGTX and MXCT are from the Healthcare sector.

5-Year PerformanceMXCT has outperformed CGTX, delivering a return of -27.4% compared to -35.0%

CGTX vs MXCT - Performance Comparison

Key Characteristics

Financial metrics and valuation ratios

Market Cap
CGTX
$130M
Winner
MXCT
$130M
Max Drawdown
CGTX
98.16%
Winner
MXCT
96.07%
Sharpe Ratio
Winner
CGTX
1.93
MXCT
-0.47
5Y Beta
CGTX
1.84
Winner
MXCT
1.29
Industry
CGTX
Biotechnology
MXCT
Medical Devices
P/E Ratio
CGTX
-3.05
Winner
MXCT
-3.30
5Y EPS CAGR
CGTX
N/A
MXCT
12.02%
Debt to Equity
CGTX
0.00%
MXCT
0.00%
Free Cash Flow Yield
Winner
CGTX
-15.63%
MXCT
-22.65%
P/S Ratio
CGTX
N/A
MXCT
4.01
P/B Ratio
CGTX
4.31
Winner
MXCT
0.76

CGTX vs MXCT - Historical Returns

Returns include dividend reinvestment.

1M
Winner
CGTX
+33.33%
MXCT
+13.46%
3M
CGTX
+48.67%
Winner
MXCT
+55.90%
6M
Winner
CGTX
+5.66%
MXCT
-27.61%
1Y
Winner
CGTX
+547.40%
MXCT
-45.62%
5Y(CAGR)
CGTX
-35.03%
Winner
MXCT
-27.40%
Max(CAGR)
CGTX
-35.03%
Winner
MXCT
-4.48%

CGTX vs MXCT - Annual Returns (2019 - 2026)

Returns include dividend reinvestment.

YearCGTXMXCT
2026+14.29%-23.87%
2025+86.70%-62.65%
2024-63.85%-16.80%
2023-9.76%-8.20%
2022-66.40%-49.63%
2021-50.51%+525.15%
2020N/A+0.00%
2019N/A+2.31%

CGTX vs MXCT Drawdown Comparison

The maximum drawdown for CGTX was -98.16%, occurring on May 30, 2025. This drawdown has not yet recovered.

The maximum drawdown for MXCT was -96.07%, occurring on Mar 30, 2026. This drawdown has not yet recovered.

The current CGTX drawdown is -87.06%. The current MXCT drawdown is -93.14%.

RankCGTXMXCT
#1-98.16%
Nov 9, 2021 - May 30, 2025
-96.07%
Sep 3, 2021 - Mar 30, 2026
#2-6.81%
Oct 8, 2021 - Nov 9, 2021
-37.58%
Jan 22, 2021 - Jul 30, 2021
#3N/A-19.65%
Jul 30, 2021 - Sep 3, 2021

Correlation

Correlation between CGTX and MXCT is 0.76 which considered as a strong positive correlation - the stocks tend to move together.

0.76
-101

Select Stocks to Compare